SS Innovations International Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, has appointed veteran medtech finance executive Sarah M. Romano as chief financial officer, effective August 3, 2026. Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology, having raised more than $100 million during her career. The appointment comes as SS Innovations continues pursuing U.S. FDA clearance for its SSi Mantra surgical robotic system while expanding internationally.
Romano joins SS Innovations after serving as CFO at Vicarious Surgical, another developer of robotic surgical technologies, where she oversaw financial and operational initiatives designed to reduce cash burn and strengthen the company’s balance sheet. Her expertise in capital markets and medtech finance is expected to support SS Innovations as it advances regulatory initiatives and broadens commercialization of the SSi Mantra platform. The company recently graduated the inaugural class of its SS International Centre for Robotics Surgery (SSICRS) cardiac robotic surgery training program, which welcomed 33 healthcare professionals from seven countries. This underscores the company’s emphasis on surgeon education alongside technology deployment.
The appointment of Romano signals SS Innovations’ commitment to strengthening its financial leadership as it prepares for potential FDA review and expands its global footprint. The company’s newsroom provides updates on its progress (https://nnw.fm/SSII). With the new CFO, SS Innovations aims to navigate the complexities of regulatory approvals and scale its operations in the competitive surgical robotics market.
